NCT05093634Phase 3Completed

EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-12-19Actual
Enrollment · participants296Actual
Source updated2026-11-12Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Difference in mean change in body weight in patients treated with setmelanotide compared to placebo, assessed as percent change in BMI Time frame: Baseline to 52 weeks. After: Measure: Treatment Period: Percent Change From Baseline in Body Mass Index (BMI) Description: BMI was calculated using participant's weight and height assessments as weight in kilograms (kg)/(height in meters \[m\])\^2. Baseline was defined as the last available measurement taken prior to the start of treatment administration. An analysis of covariance (ANCOVA) model was used to calculate the least-squares mean with randomization stratification factors and baseline value as a covariate. Time frame: Baseline, Week 52.

Primary completion date changed

Before: 22 Dec 2025. After: 19 Dec 2025.

Check registry source

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 400 participants (planned). After: 296 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2025. After: 22 Dec 2025.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview